Apixaban Outmatches Rivaroxaban for VTE in Study

These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the study.

Related Keywords

New York ,United States ,University Of Pennsylvania ,Pennsylvania ,Philadelphia ,Rochester ,Ghadeerk Dawwas ,Colleen Edwards ,Thomas Wakefield ,Damone Houghton ,Icahn School Of Medicine At Mount Sinai ,University Of Michigan Health Frankel Cardiovascular Center ,Clinformatics Data Mart ,May Have Missed Some Nuance ,Possible Outcomes ,Michigan Health Frankel Cardiovascular Center ,Ann Arbor ,Mayo Clinic ,Trial Needed ,Says Hematologist ,Icahn School ,Mount Sinai ,Thromboembolism ,Venous Thromboembolism ,Deep Venous Thrombosis Dvt ,Deep Vein Thrombosis ,Vt Deep Venous Thrombosis ,Pulmonary Embolism ,Ulmonary Embolism Pe ,Pulmonary Embolus ,Mbolism Pulmonary ,Anticoagulation Therapy ,Anticoagulant ,Anticoagulation ,Gastrointestinal Hemorrhage ,Gastrointestinal Bleeding ,Leeding Gastrointestinal ,Hemorrhage ,Bleeding ,Hematology ,Intracranial Hemorrhage ,